Fiche centre
University Health Network - Princess Margaret Cancer Centre
Toronto — Canada
Essais liés3clinical trials
VilleTorontolocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07628751
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Radiofrequency Ablation of Papillary Thyroid Cancer | Cancer | Non applicable | NCT07376837 | PTC-RFA — Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study | RECRUITING |
| Stereotactic Ablative Body Radiotherapy (SABR) | Cancer | Non applicable | NCT07628751 | SOCRATES HCC — A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC | RECRUITING |
| Precemtabart tocentecan | Cancer | Phase 3 | NCT07549412 | A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) | RECRUITING |